Global Collagen Market Shifting Toward Clinically Proven Bioactives
Summary
The global collagen market is changing as companies focus on proving their products work through scientific studies. Sel Sanayi, with its CollaSel brand, has published several peer-reviewed studies showing its collagen peptides may be more effective than typical products. This shift is driven by stricter rules and smarter customers who want clinically proven health benefits.Key Facts
- The collagen market is moving from broad health claims to clinical proof backed by research.
- Sel Sanayi’s CollaSel has three recent peer-reviewed studies validating its collagen peptides.
- One study found CollaSel Tripeptide has stronger biological activity relevant to heart and metabolic health compared to standard collagen.
- Two clinical trials showed CollaSel Pro improved skin health and reduced joint pain in osteoarthritis patients.
- CollaSel peptides are much smaller in molecular size (300-500 Daltons) than typical collagen (2,000-5,000 Daltons).
- The smaller size may help the peptides absorb better in the body, increasing exposure by about 2.7 to 3.3 times.
- Sel Sanayi treats clinical validation as a key part of making their products, not just marketing.
- Regulatory agencies in the US and Europe require stronger scientific evidence for health claims, influencing market trends.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
